BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3358861)

  • 1. Neuropeptide-dopamine interactions. II. Cyclo (His-Pro) augmentation of amphetamine- but not apomorphine-induced stereotypic behavior.
    Prasad C
    Behav Brain Res; 1988 Mar; 27(3):241-5. PubMed ID: 3358861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide-dopamine interactions. I. Dopaminergic mechanisms in cyclo(His-Pro)-mediated hypothermia in rats.
    Prasad C
    Brain Res; 1987 Dec; 437(2):345-8. PubMed ID: 3435841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cyclo(His-Pro) act like amphetamine?
    Mizuma H; Shimizu I; Hilton C; Prasad C
    Life Sci; 1994; 54(21):1625-33. PubMed ID: 8196482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates.
    Kuczenski R; Segal DS; Manley LD
    J Neurochem; 1990 May; 54(5):1492-9. PubMed ID: 2324735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
    Cools AR; Scheenen W; Eilam D; Golani I
    Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
    Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo (His-Pro), d-amphetamine and striatal dopamine: a microdialysis study.
    Levy A; Stillman MJ; Rauch TM
    Brain Res Bull; 1991 Jul; 27(1):129-31. PubMed ID: 1933425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
    Fields JZ; Wichlinski L; Drucker GE; Engh K; Gordon JH
    Pharmacol Biochem Behav; 1991 Dec; 40(4):881-6. PubMed ID: 1816575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histidyl-proline diketopiperazine: its biological role as a regulatory peptide.
    Peterkofsky A; Battaini F; Koch Y; Takahara Y; Dannies P
    Mol Cell Biochem; 1982 Jan; 42(1):45-63. PubMed ID: 6278283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between recovery from behavioral asymmetries induced by hemivibrissotomy in the rat and the effects of apomorphine and amphetamine.
    Milani H; Schwarting RK; Kumpf S; Steiner H; Huston JP
    Behav Neurosci; 1990 Jun; 104(3):470-6. PubMed ID: 2354040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of environmental context in the development of amphetamine- or apomorphine-induced stereotyped behavior after single and multiple doses.
    Battisti JJ; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 2000 Aug; 66(4):671-7. PubMed ID: 10973502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum.
    Martin-Iverson MT; Radke JM; Vincent SR
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1707-14. PubMed ID: 2874568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.